PMC6791014_01
Fundus color picture showing (a) an unremarkable posterior pole and (b) subretinal, elevated, rounded, yellowish lesion in the nasal region in the right eye. c Similar lesion superior to the macula were found in the left eye
40942_2019_185_Fig1_HTML.jpg
PMC6791014_01_40942_2019_185_Fig1_HTML.jpg
Fig1
Fundus examination revealed subretinal, elevated, rounded, yellowish lesions in the nasal region in the right eye and superior to the macula in the left eye (Fig. 1). 
Fluorescein angiography of the right (a-c) and left eye (d, e). The subretinal lesions revealed punctate leakage in both eyes
40942_2019_185_Fig2_HTML.jpg
PMC6791014_01_40942_2019_185_Fig2_HTML.jpg
Fig2
On fluorescein angiography (FA), these lesions showed punctate leakage (Fig. 2).
Optical coherence tomography of the lesions of the right (a) and left (b) eye showing choroidal lesions causing elevation of the retinal pigment epithelium and subretinal fluid
40942_2019_185_Fig3_HTML.jpg
PMC6791014_01_40942_2019_185_Fig3_HTML.jpg
Fig3
The optical coherence tomography (OCT) revealed choroidal lesions causing elevation of the retinal pigment epithelium (RPE) and subretinal fluid (Fig. 3).  
Fundus color picture after 6 months of specific treatment showing (a) an unremarkable posterior pole in the right eye and regression of the subretinal lesion achieving the appearance of atrophy in the (b) right and left (c) eyes
40942_2019_185_Fig4_HTML.jpg
PMC6791014_01_40942_2019_185_Fig4_HTML.jpg
Fig4
After 6 months of targeted treatment, the fundus exam revealed a significant regression of the lesions (Fig. 4).
Fluorescein angiography of the right (a-c) and left eye (d, e) 6 months after targeted treatment was initiated. The lesions in the right eye showed discrete leakage and areas of window defect and the lesions in the left eye still demonstrated mild leakage
40942_2019_185_Fig5_HTML.jpg
PMC6791014_01_40942_2019_185_Fig5_HTML.jpg
Fig5
The FA still showed discrete leakage (Fig. 5) and the OCT demonstrated regression of the choroidal lesion and subretinal fluid, which were replaced by areas of retinal atrophy (Fig. 6).